Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT01349712
Other study ID # MOB 0158
Secondary ID
Status Unknown status
Phase N/A
First received April 29, 2011
Last updated May 5, 2011
Start date May 2011
Est. completion date November 2011

Study information

Verified date May 2011
Source Universal Biosensors Pty Ltd
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to measure prothrombin time (PT) on an experimental device and a commercially available device on persons receiving coumadin (warfarin)treatment.


Description:

This study will require participants to have up to 2 finger-punctures taken and sample tested on a strip and meter system for both the experimental and commercially available devices.


Recruitment information / eligibility

Status Unknown status
Enrollment 200
Est. completion date November 2011
Est. primary completion date November 2011
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Currently taking coumadin (warfarin)

- Aged 18 years or older

- Able and willing to provide informed consent

- Can understand (read and write) English

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States White River Diagnostic Clinic Batesville Arkansas

Sponsors (1)

Lead Sponsor Collaborator
Universal Biosensors Pty Ltd

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary PT/INR values from the experimental device will be statistically correlated to results obtained from a commercially available device To determine the correlation of PT/INR values between an experimental and commercial device. Fives days to collect data and up to two weeks to generate correlation graph
See also
  Status Clinical Trial Phase
Recruiting NCT02239991 - Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant N/A
Completed NCT01435304 - The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass N/A
Completed NCT00969319 - Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America N/A
Completed NCT00091494 - Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA N/A
Completed NCT00005481 - Epidemiology of Impaired Coagulant Balance in Diabetes N/A
Recruiting NCT02379104 - ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals N/A
Withdrawn NCT02774317 - Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months Phase 4
Recruiting NCT01930916 - Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients N/A
Completed NCT00168090 - Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) Phase 4
Completed NCT01787552 - A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF Phase 1/Phase 2
Not yet recruiting NCT02782338 - The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin N/A
Completed NCT01143909 - Transfusion of Fresh Frozen Plasma in Non-bleeding Intensive Care Unit (ICU) Patients N/A
Recruiting NCT04762550 - Thrombin Generation in Liver Transplant Surgery
Withdrawn NCT01221389 - Study Using Plasma for Patients Requiring Emergency Surgery Phase 4
Withdrawn NCT00233246 - Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures Phase 3
Recruiting NCT03884725 - Fibrinogen Concentrate In Children Cardiac Surgery 2 Phase 4
Completed NCT00086476 - Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles N/A
Completed NCT00516126 - Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery Phase 4
Completed NCT00708435 - Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy Phase 3
Recruiting NCT00214656 - "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery Phase 3